AstraZeneca Resumes COVID-19 Vaccine Trials in the UK

Shots:

• AstraZeneca has resumed the clinical trial of AZD1222 in the UK, following the MHRA’s confirmation that it is safe to resume the trial
• On Sept 06, 2020, the standard review process triggered a voluntary pause to all global trials, allowing review of safety data by independent committees, and international regulators. The UK committee has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume
• AstraZeneca will continue to work with health authorities across the globe and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably, and at no profit during COVID-19

Click here ­to­ read full press release/ article | Ref: AstraZeneca | Image: Asian Times